<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are a group of <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> clonal stem cell diseases with a tendency to progress to leukemic transformation </plain></SENT>
<SENT sid="1" pm="."><plain>The cytogenetic and molecular pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> has not been well understood </plain></SENT>
<SENT sid="2" pm="."><plain>SALL4, a newly identified oncogene, modulates stem cell pluripotency and self-renewal capability in embryonic development and also plays a role in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Overexpression of SALL4 induces <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-like features and subsequent leukemic progression in transgenic mice </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we examined SALL4 expression levels in bone marrow mononuclear cells from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) patients, and <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects using a semiquantitative reverse transcription polymerase chain reaction </plain></SENT>
<SENT sid="5" pm="."><plain>Higher levels of SALL4 expression were seen in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> samples than in control samples </plain></SENT>
<SENT sid="6" pm="."><plain>The expression level of SALL4 positively correlated with those of MYC and CCND1, both of which are downstream target genes in the Wnt/beta-catenin pathway </plain></SENT>
<SENT sid="7" pm="."><plain>We therefore propose that SALL4 plays a critical role in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> by causing the aberrant activation of the Wnt/beta-catenin pathway </plain></SENT>
</text></document>